Last reviewed · How we verify

NCT03859726

Predictive Value of Sublingual Microcirculation and Peripheral Tissue Oxygen Monitoring

Completed Last updated 27 July 2020
What this trial tests

trial testing NIRS in Sepsis in 72 participants. Completed in 31 March 2020.

Timeline
20 March 2019
Primary endpoint
31 March 2019
31 March 2020

Quick facts

Lead sponsorXiangya Hospital of Central South University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment72
Start date20 March 2019
Primary completion31 March 2019
Estimated completion31 March 2020
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Xiangya Hospital of Central South University

Who can join

18 and older, any sex, with Sepsis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Change and predictive Value of Sublingual Microcirculation and Peripheral Tissue Oxygen Monitoring in Sepsis Patients With Successful Fluid Resuscitation

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Assessment of Sublingual Microcirculation to Evaluate the Efficacy of Resuscitation Therapy in Septic Shock Patients: A Cohort Study.
    Zhang X, Zhang H, Jin R, Li L, et al · · 2026 · PMID 41031817 · DOI 10.1097/shk.0000000000002708

Verify or expand the search:

Other trials of NIRS

Trials testing the same drug.

Other recruiting trials for Sepsis

Currently open trials in the same condition.

Other Xiangya Hospital of Central South University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03859726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing